Axcella Health Inc.
AXLA
NSD
Sector: Healthcare
Industry: Biotechnology
2.47
USD
-0.05
(-1.98%)
Optionable: Yes Market Cap: 74 M 90-day average vol: 0
Previous close: 2.52 Open: 2.54 Bid: 2.59 Ask: 2.59
52 week range
0.00 0.00
Last updated: Monday 8th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs
Yahoo Finance 2/28/2022
Axcella Health (AXLA) Investor Presentation - Slideshow
Seeking Alpha 2/24/2022
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
Yahoo Finance 2/15/2022
Axcella granted FDA’s Fast Track Designation for NASH candidate
Seeking Alpha 2/14/2022
Axcella Therapeutics Announces FDA Fast Track Designation for AXA1125 in NASH
Yahoo Finance 2/14/2022
Axcella Therapeutics to Participate in the SVB Leerink Global Healthcare Conference
Yahoo Finance 2/10/2022
Axcella Therapeutics picks industry veteran for CFO role
Seeking Alpha 2/7/2022
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
Yahoo Finance 2/7/2022
Axcella Health Inc. (AXLA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Yahoo Finance 1/25/2022
Here's Why You Should Retain Cigna (CI) in Your Portfolio
Yahoo Finance 1/13/2022
Axcella Health (AXLA) Investor Presentation - Slideshow
Seeking Alpha 1/11/2022
Axcella Health updates on 2022 milestones
Seeking Alpha 1/6/2022
Axcella Therapeutics Details Clinical and Operational Milestones for 2022
Yahoo Finance 1/6/2022
Axcella Therapeutics to Present at the H.C. Wainwright BioConnect Conference
Yahoo Finance 1/4/2022
Here's Why You Should Retain UnitedHealth Group (UNH) Now
Yahoo Finance 12/31/2021
Down 24% in 4 Weeks, Here's Why Axcella Health Inc. (AXLA) Looks Ripe for a Turnaround
Yahoo Finance 12/30/2021
Axcella Kickstarts Long COVID Phase 2 Clinical Trial
Yahoo Finance 12/16/2021
Axcella Therapeutics Announces Initiation of AXA1125 Long COVID Phase 2a Clinical Trial
Yahoo Finance 12/16/2021
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!